miR-27b synergizes with anticancer drugs via p53 activation and CYPIB1 suppression
Liver and kidney cancers are notorious for drug resistance. Due to the complexity, redundancy and interpatient heterogeneity of resistance mechanisms, most efforts targeting a single pathway were unsuccessful. Novel personalized therapies targeting multiple essential drug resistance pathways in para...
Saved in:
Published in | 细胞研究:英文版 no. 4; pp. 477 - 495 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!